USAID, PEPFAR Brief Addresses Hormonal Contraception Use, HIV Risk
September 16, 2013
"While evidence of a tie between some injectable hormonal contraceptives and an increased risk of HIV acquisition remains incomplete, that potential risk must be balanced against the life-saving benefits of preventing unintended pregnancy, a brief [.pdf] from USAID's Office of Population and Reproductive Health says," the Center for Global Health Policy's "Science Speaks" blog reports. The brief, prepared in collaboration with PEPFAR, "concludes that the search for conclusive evidence of acquisition risk, as well as for safe, affordable technologies to prevent both unintended pregnancy and HIV acquisition, continues," the blog notes (Barton, 9/13).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)